Your browser doesn't support javascript.
loading
Case Report: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Relapse With COVID-19.
Woodhall, Mark; Mitchell, James W; Gibbons, Emily; Healy, Sarah; Waters, Patrick; Huda, Saif.
Afiliação
  • Woodhall M; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
  • Mitchell JW; Department of Neurology, Walton Centre NHS Foundation Trust, Liverpool, United Kingdom.
  • Gibbons E; Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
  • Healy S; Department of Neurology, Walton Centre NHS Foundation Trust, Liverpool, United Kingdom.
  • Waters P; Department of Neurology, Walton Centre NHS Foundation Trust, Liverpool, United Kingdom.
  • Huda S; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
Front Neurol ; 11: 598531, 2020.
Article em En | MEDLINE | ID: mdl-33324337
A 39-year-old lady with relapsing myelin oligodendrocyte glycoprotein antibody (MOG-IgG) associated disease developed coryzal symptoms, malaise, sweating, and postural dizziness. Six days later she presented with painful progressive right visual loss consistent with optic neuritis. COVID-19 was confirmed by nasopharyngeal swab and MOG-IgG serological reversion was noted. Visual function improved following steroids and plasma exchange. This case highlights a possible causal association between inflammation due to COVID-19 and a relapse of MOG-IgG associated disease. It also highlights the clinical relevance of reporting MOG-IgG titers in MOG-IgG associated disease.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article